KeaneW.F., BailieG.R., BoeschotenE., GokalR., GolperT.A., HolmesC.J.Adult peritoneal dialysis related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20: 828–9.].Perit Dial Int2000; 20: 396–411.
3.
SandoeJ.A., GokalR., StruthersK.Vancomycin-resistant enterococci and empirical vancomycin for CAPD peritonitis.Perit Dial Int1997; 17: 617–18.
4.
PirainoB.Peritonitis as a complication of peritoneal dialysis.J Am Soc Nephrol1998; 9: 1956–64.
5.
VasS., BargmanJ., OreopoulosD.G.Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics.Perit Dial Int1997; 17: 91–4.
6.
National Committee for Clinical Laboratory Standards.Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically.5th ed.Wayne, PA: National Committee for Clinical Laboratory Standards; 2000: Approved Standard M7-A5.
7.
LaiM.N., KaoM.T., ChenC.C., CheungS.Y., ShungW.K.Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis.Perit Dial Int1997; 17: 87–8.
8.
ArianoR.E., FranczukC., FineA., HardingG.K., ZelenitskyS.A.Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.Perit Dial Int2002; 22: 335–8.
9.
KhairullahQ., ProvenzanoR., TayebJ., AhmadA., BalakrishnanR., MorrisonL.Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.Perit Dial Int2002; 22: 339–44.
10.
ManleyH.J., BailieG.R., AsherR.D., EiseleG., FryeR.F.Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1999; 19: 65–70.
